23andMe and Montreal: Reflections From ICHG 2011

October 31, 2011
Ever since Kevin Davies coined the phrase "the $1000 genome" the vision of whole genomes at the corner store has alternately inspired and unsettled onlookers. Well, we're not quite at the point where getting your genome sequenced costs less than buying a smartphone, but sequencing is definitely still rising in popularity. Nowhere was this more evident than at the 12th International Congress of Human Genetics (ICHG) held three weeks ago in Montreal. 23andMe's 11 scientists in attendance presented 10 scientific posters and soaked in four full days of the latest in human genetics (and a bit of the charms of Montreal).
Read More

Milestones in the Fight Against Parkinson’s Disease

October 25, 2011
It's been an exciting year for research on Parkinson's disease, and now 23andMe is adding yet another discovery to the mix -- a genetic factor that may protect against Parkinson's in individuals carrying the high-risk G2019S LRRK2 variant.
Read More

“50/50” Shows Us the Human Side of Cancer

October 10, 2011
From the minute it became clear that Adam had cancer, he became a statistic, a diagnosis, a “case study”. The odds -- 50/50 -- didn’t seem fair in the context of his life, but his friend Kyle put it into a different perspective: “Dude, if you were a casino game, you’d have the best odds!” Thus begins Adam’s journey with neurofibrosarcoma, a rare form of spinal cancer, in the surprising and transformative new film "50/50", starring Joseph Gordon-Levitt and Seth Rogen.
Read More

SNPWatch: Genetic Variation Influences How We Respond to Reinforcement

September 20, 2011
Genetics can influence everything from how we respond to different drugs to what techniques help us learn. One genetic variant in particular, located in a gene involved in detecting opioid chemicals like morphine, was previously linked to alcohol and heroin addiction as well as how we react to social rejection. Now a new study finds a connection between this same variant and how humans respond to positive reinforcement.
Read More

FDA to Hold Public Town Hall Discussion in San Francisco

August 25, 2011
In March earlier this year, 23andMe presented its views on possible federal regulation of the direct-to-consumer (DTC) genetic testing industry at an Advisory Committee meeting convened by the FDA. We...
Read More

23andMe replicates over 180 genetic associations

August 17, 2011
As we’ve mentioned here previously, science can be a slow process. Researchers spend a long time — sometimes upward of five years — gathering enough people with a particular disease...
Read More

Controversial Longevity Paper Formally Retracted

July 22, 2011
Last summer, a study published in the journal Science on the genetics of human longevity made a splash when the authors claimed that they had identified a genetic signature that...
Read More

SNPwatch: Genetic Variants Linked to Progressive Supranuclear Palsy

July 15, 2011
Progressive supranuclear palsy (PSP) is a rare movement disorder caused by damage to certain areas of the brain. People with PSP experience increasing difficulty balancing and walking and suffer from...
Read More

A Recipe for Disease Research: Give People Tools, Add Passion, and Shake

July 06, 2011
[Update: View a video recap of Sarcoma Community Night at http://www.23andme.com/sarcoma/] Three. That was the average number of patients enrolled in studies for sarcoma four years ago when Nathalie Criou,...
Read More

Ethnicity Matters in Research: A Case Study in Prostate Cancer

June 27, 2011
By Angela Liu and Shirley Wu Nearly one in six men in the United States develops prostate cancer. This sobering statistic has spurred tremendous advances in research over the years,...
Read More